Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wow! You have direct access to the Koots wreck room cam where we can see Koots at work doing what he does best...
You so lucky!
Ouch!
I get the feeling that the biggest pumpers will be the biggest dumpers. Does anyone here have the slightest idea of what the science is about? No. Undeniably.
A load of crap..Undeniable.
A load of crap..Undeniable.
In a nutshell. This mindless pumping is nothing but a disservice to those looking for timely and accurate information on Koots and his company.
Oh yeh, the patents..
From the google search: "Acute promyelocytic leukemia is invariably associated with gene fusions involving the retinoic acid receptor a (RARa) and one of five different partners, PML, PLZF, NPM, NuMA, and STAT5b. Patients with this disease respond to treatment with the RARa ligand, all trans retinoic acid (ATRA). Dominant negative mutants of RARa enhance mast cell development and reduce granulocyte and macrophage development in multipotential haematopoietic cell lines, and also block myeloid development in transduced murine bone marrow. Although targeted disruption of RARa in the mouse has little effect on haematopoiesis, in vitro studies revealed an increased proportion of morphologically immature granulocytes in RARa1/RAR? double mutants. In addition to this, in vitro studies suggest a role for the thyroid hormone receptor in erythropoiesis and for the PPAR? in monocyte/macrophage development. A role for the vitamin D receptor in myeloid differentiation is suggested by 1,25-dihydroxyvitamin D3-induced terminal differentiation and cell cycle arrest of a variety of leukaemic cell lines. Although little is known of the downstream genes regulated by NRs in haematopoiesis, evidence suggests that the cdk inhibitor p21 and the transcription factor C/EBPe may be targets of RARa in myelopoiesis."
How is the average investor to understand this? There's a lot of hub bub on Ihub but nothing in the scientific community.
But the NR2F6 nuclear receptor has been well known for many years. Regen didn't invent it as it was a discovery.
The agonists and antagonists of the NR2F6 nuclear receptor are something that Regen has been working on however.
Now show me something of worth please.
A simple google search using the keywords mrna and Regen yields one result:
https://www.biospace.com/article/releases/oncology-pharma-inc-addresses-pancreatic-cancer-the-need-for-an-effective-therapy-and-the-potential-of-mrna-technology/
It's an article in a trade magazine about ONPH published last April.
But can we fully understand a scientific paper? It's like Greek to most of us. There are no layman directed summaries or a synopsis provided with these to give us a clear understanding of the implications of the theses or findings.
As far as Ichim or Landers, as CSO's, they had a duty to provide an overview to shareholders, but they also had a direct stake.
This is over five years old. Where's the recent news?
But who here fully understands the science or has a degree in biochemistry?
If you are correct, then maybe, but there are a lot of assumptions being made here about the science that are really above our pay grade.
Oh Jeez..
Disingenuous. Nothing came of Hexcellerate after approval several years ago. Why are you putting this out today?
Well, ONCO is seeing a reversal...
Been here a long long time too. Hope it pans out for Koots and shareholders.
Show proof please.
Why can't big pharma see the value of these patents? You'd think if there was something of value there, we'd hear about it. Any news stories, medical articles or even yellow journalism out there talking about RGBP's NR2F6 agonist/antagonist stuff or any of the past achievements like Hexacellerate?
The wind can certainly turn foul after Koot's all night taco fest!
Best of luck to you and stay positive.
Why??
'Cause Koots is in debt up to his tacos and had to do something to inflate the stock price.
RGBP cited by the Ruskies?
What..for a bloated share structure and a bloated CEO?
Well, for once those election meddlers and crooks are giving it to us straight up.
Hey, where did everyone go?
Could they have moved on, leaving a trail of bagholders?
Awesome deduction. After applying Occam's razor to this great mystery, nothing else makes sense.
That's right!
Dolly says it straight up.
Nuthin' wrong with bouncin' around two cents!
Ya'all can get real lucky with a good bounce from an online kick!
A nice sing-a-long with the bouncing ball is always fun..
Bouncers? Everyone's favorite!
Except maybe my buddy lil' Nasty X here..
Who'd rather bounce off a bottom boy..
No matter who you are, there's nuthin' wrong with just bouncin' along!
Seems there was a problem with standards a few years back..
https://pcaobus.org/Inspections/Reports/Documents/104-2017-084-DBBMCKENNON.pdf
Well, I've had three covid shots but am now surprised to learn that I and other vaccinated people can transmit the disease to others. I've heard firsthand of an unvaccinated person who got covid from a vaccinated grandmother.
On the other hand, the vaccine, along with social distancing and masking are the best defenses we have at this time. What pisses me off are the individuals who refuse to mask up.
Southbound.
Mortgage the kids and sell the house...
Next week is gonna be epic!
Only thing is, just like tomorrow, next week never comes.
C'mon Koots...
Lay a nice fat 8K on us right now before this goes any lower!
Nothin' wrong with bein' a little down..
Goin' down the big dip at Dollyland is a real thrill!
Goin down to the local honky tonk is fun..
My buddy Lil Nasty X here goes down a lot!
When you're feelin' a little down, don't ya'all worry.. Jes' pin your hopes to a shinin' star and things will start lookin' up real soon!
This is gonna bounce like a rubber taco..
Hard to understand why Koots would turn down Lilly in favor of ONCO.
He's such a great business man, guess we gotta trust him to do the right thing...
Nah!
Gotta remember there's close to 4 billion shares...Thats really bloated.
RS is the only option for Koots going forward.
Whoopsi!
Koots better pull a rabbit outa his hat.